The Bipartisan Budget Act of 2018 (BBA 2018, P.L. 115-123 ), which was enacted on February 9, 2018, addresses a number of issues that were before Congress. Specifically, appropriations for most federal agencies and programs were set to expire on February 8, 2018, and BBA 2018 extends continuing appropriations for these agencies and programs through March 23, 2018. In addition, BBA 2018 includes FY2018 supplemental appropriations, an increase to the debt limit, increases to the statutory spending limits for FY2018 and FY2019, tax provisions, and numerous provisions extending or making changes to mandatory spending programs, among other topics. Division E of BBA 2018 is titled the Advancing Chronic Care, Extenders, and Social Services (ACCESS) Act, which includes provisions affecting the following programs: Medicare; Medicaid; the State Children's Health Insurance Program (CHIP); public health programs; the Maternal, Infant, and Early Childhood Home Visiting (MIECHV) program; foster care and child welfare; social impact partnerships; child support enforcement; and prison data reporting. This report provides information about the provisions from Division E of BBA 2018 related to CHIP, certain public health programs, the MIECHV program, and the Medicaid program. It covers Division E provisions related to four topics: CHIP (§§50101-50103). Public Health Extenders (§§50501-50503, §50611, §50901, §50902, and §53119). MIECHV (§§50601-50607). Medicaid (§§53101-53105). This report provides high-level summaries for each topic followed by a table with abbreviated summaries of each provision. The four sections following the table provide more detailed summaries of these provisions related to each topic. Below is a high-level summary of the four sections of this report: CHIP, public health extenders, MIECHV, and Medicaid. The table following these summaries provides abbreviated summaries for each provision. CHIP is a means-tested program that provides health coverage to targeted low-income children and pregnant women. At the start of FY2018 (i.e., on October 1, 2017), there was no funding for FY2018 CHIP allotments to states. States were able to continue funding the federal share of their CHIP programs with unspent funds from FY2017 allotments and unspent allotments from FY2016 and prior years redistributed to shortfall states. In addition, continuing resolutions enacted on December 8, 2017 ( P.L. 115-90 ), and December 22, 2017 ( P.L. 115-96 ), included provisions that provided short-term funding for CHIP. The continuing resolution enacted on January 22, 2018 ( P.L. 115-120 ), provided federal CHIP funding for FY2018 through FY2023. P.L. 115-120 also extended other CHIP-related provisions through FY2023, among other things. These other CHIP-related provisions include the Child Enrollment Contingency Fund, the qualifying states option, the Express Lane Eligibility option, the maintenance of effort (MOE) for children, the Pediatric Quality Measures Program, and the outreach and enrollment program. BBA 2018 further extends CHIP funding and these other CHIP-related provisions through FY2027. According to the Congressional Budget Office (CBO) cost estimate, the CHIP provisions in BBA 2018 are estimated to reduce federal spending by $0.3 billion and increase revenues by $4.6 billion, for a net savings of $4.9 billion over the period of FY2018 through FY2027. BBA 2018 extends funding for a number of public health programs funded through mandatory appropriations. In some cases, funding for those programs had ended at the end of FY2017 (i.e., September 30, 2017), while in others, funding had been provided for one or more quarters of FY2018. Among the programs that receive additional funding through BBA 2018 for FY2018 and FY2019 are two Special Diabetes Programs, the Health Professions Opportunity Grant Program, and the National Health Service Corps. These programs are largely extended without programmatic changes. BBA 2018 also extends or increases FY2018 and FY2019 mandatory funding for—and makes programmatic changes to—the Family-to-Family Health Information Program, an abstinence education program now known as the Sexual Risk Avoidance Education program; the Personal Responsibility Education Program (which relates to teen pregnancy prevention); the health center program; and the teaching health center graduate medical education program. In some cases, legislation had been introduced that would have extended funding for these programs, but no long-term funding extensions had been enacted prior to BBA 2018. In addition to the funding extensions included in the BBA 2018, the law reduces the amounts appropriated to the Public Health and Prevention Fund as a funding offset. According to the CBO cost estimate, the public health provisions in Division E of BBA 2018 are estimated to increase federal spending by a net of $8.0 billion over the period of FY2018 through FY2027. The MIECHV program provides grants to states, territories, and tribes ("eligible entities") in support of evidence-based early childhood home visiting. Home visiting entails in-home visits by health or social service professionals with at-risk families. BBA 2018 extends mandatory funding of $400 million for the program for each of FY2017 through FY2022. The law requires eligible entities to continue to track and report on program performance measures. Eligible entities must also conduct a new statewide needs assessment to determine which communities are most at risk of poor child and family outcomes and to identify resources that can support those communities. Further, the law requires the U.S. Department of Health and Human Services (HHS) to designate data exchange standards to govern state and federal reporting on home visiting, and directs HHS to use the most accurate federal population and poverty data available for each eligible entity that is awarded funds. Under the BBA 2018, jurisdictions may use some MIECHV funding for a pay-for-outcomes initiative. According to the CBO cost estimate, the MIECHV program provisions in BBA 2018 are estimated to increase federal spending by $2.0 billion over the period of FY2018 through FY2027. BBA 2018 includes some Medicaid provisions as offsets. These Medicaid offsets are (1) modifying the reductions to Medicaid disproportionate share hospital (DSH) allotments; (2) making various changes to the third-party liability (TPL) rules; (3) requiring states to consider "qualified lottery winnings" and/or "qualified lump sum income" when determining Medicaid eligibility for certain individuals; (4) changing the rebate obligation with respect to line-extension drugs; and (5) rescinding funds from the Medicaid Improvement Fund. According to the CBO cost estimate, the Medicaid provisions in Division E of BBA 2018 are estimated to reduce federal spending by $11.3 billion over the period of FY2018 through FY2027. Table 1 provides a high-level summary of the provisions under Division E of BBA 2018 for CHIP, public health, the MIECHV program, and Medicaid. For each provision, the section of the law, the title of the provision, a summary of the provision, and a CRS contact are provided. This section provides more detailed summaries of the provisions under Division E of BBA 2018 for CHIP, public health, the MIECHV program, and Medicaid. For each provision, there is a background summary followed by an explanation of the provision in BBA 2018. Prior to the enactment of BBA 2018, CHIP was funded through FY2023 with appropriated amounts specified in statute. Since CHIP was first established in 1997 in the Balanced Budget Act of 1997 (BBA97, P.L. 105-33 ), it has been funded through subsequent legislation, including the following major laws: the Children's Health Insurance Program Reauthorization Act of 2009 (CHIPRA; P.L. 111-3 ), which provided federal CHIP funding for FY2009 through FY2013; the Patient Protection and Affordable Care Act (ACA; P.L. 111-148 , as amended), which provided federal CHIP funding for FY2014 and FY2015; the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA, P.L. 114-10 ), which provided funding for FY2016 and FY2017; and the continuing resolution enacted on January 22, 2018 ( P.L. 115-120 ), which provided funding for FY2018 through FY2023. The annual appropriation amounts for FY2018 through FY2022 increase annually from $21.5 billion in FY2018 to $25.9 billion in FY2022. The FY2023 appropriation is a combination of semiannual appropriations of $2.85 billion from Section 2104(a) of the Social Security Act (SSA) and a one-time appropriation of $20.2 billion from P.L. 115-120 , which is provided for the first six months of the fiscal year and remains available until expended. Sections 50101(a) and (b)(2) extend federal CHIP funding for an additional four years by adding federal appropriations for FY2024 through FY2027 under SSA Section 2104(a). The funding amounts for FY2024 through FY2026 are not specified; instead, the appropriation provides such sums as necessary to fund allotments to states. The funding for FY2027 is structured as it is for FY2023, with semiannual appropriations of equal amounts plus a one-time appropriation. In FY2027, the semiannual appropriations are $7.65 billion, and the one-time appropriation provides such sums as necessary to fund the allotments to states after taking into account the semiannual appropriations. The federal government reimburses states for a portion of every dollar they spend on CHIP, up to state-specific annual limits, called allotments. Allotments are the federal funds allocated to each state for the federal share of its CHIP expenditures. State CHIP allotment funds are provided annually, and the funds are available to states for two years. Recently, P.L. 115-120 extended the authorization for CHIP allotments through FY2023. Two formulas are used to determine state allotments: an even-year formula and an odd-year formula. In even years, such as FY2018, state CHIP allotments are based on each state's federal allotment for the prior year. In odd years, state CHIP allotments are based on each state's spending for the prior year. In every year, the allotment amounts are adjusted for growth in per capita National Health Expenditures and child population in the state. Sections 50101(b)(1) authorizes CHIP allotments for FY2024 through FY2027 under SSA Section 2104(m), maintaining the allotment formulas for odd- and even-year allotments. CHIPRA established the Child Enrollment Contingency Fund to provide shortfall funding to certain states. It was funded with an initial deposit equal to 20% of the appropriated amount for FY2009 (i.e., $2.1 billion). In addition, for FY2010 through FY2023, such sums as are necessary for making Child Enrollment Contingency Fund payments to eligible states were to be deposited into this fund, but these transfers cannot exceed 20% of the appropriated amount for the fiscal year or period. For FY2009 through FY2023, states with a funding shortfall and CHIP enrollment for children exceeding a state-specific target level receive a payment from the Child Enrollment Contingency Fund. This payment is equal to the amount by which the enrollment exceeds the target, multiplied by the product of projected per capita expenditures and the enhanced federal medical assistance percentage (E-FMAP), which is the federal share of CHIP expenditures. Section 50101(c) extends the funding mechanism for the Child Enrollment Contingency Fund under SSA Section 2104(n) and payments from the fund for FY2024 through FY2027. In a few situations, federal CHIP funding is used to finance Medicaid expenditures. For instance, certain states had significantly expanded Medicaid eligibility for children prior to the enactment of CHIP in 1997. These states are allowed to use their CHIP allotment funds to finance the difference between the Medicaid and CHIP matching rates (i.e., federal medical assistance percentage [FMAP] and E-FMAP rates, respectively) for the cost of Medicaid-eligible children in families with income above 133% of the federal poverty level (FPL). Eleven states meet the definition: Connecticut, Hawaii, Maryland, Minnesota, New Hampshire, New Mexico, Rhode Island, Tennessee, Vermont, Washington, and Wisconsin. This provision is referred to as the qualifying state s option . Prior to the enactment of BBA 2018, FY2023 was the last year in which the qualifying states option was authorized. Section 50101(d) extends the qualifying states option under SSA Section 2105(g)(4) for FY2024 through FY2027. CHIPRA created a state plan option for Express Lane eligibility through September 30, 2013. Under this option, states are permitted to rely on a finding from specified Express Lane agencies (e.g., those that administer programs such as Temporary Assistance for Needy Families, Medicaid, CHIP, and the Supplemental Nutrition Assistance Program) for determinations of whether a child has met one or more of the eligibility requirements necessary to determine his or her initial eligibility for Medicaid or CHIP, eligibility redeterminations for Medicaid or CHIP, or renewal of eligibility coverage under Medicaid or CHIP. This provision was extended through subsequent legislation. Most recently, P.L. 115-120 extended the Express Lane eligibility option through FY2023. Section 50101(e) amends SSA Section 1902(e)(13)(I) to extend authority for Express Lane eligibility determinations for FY2024 through FY2027. Eligibility for Medicaid and CHIP is determined by both federal and state law, whereby states set individual eligibility criteria within federal standards. Statewide upper-income eligibility thresholds for CHIP-funded child coverage vary substantially across states, ranging from a low of 170% of FPL to a high of 400% of FPL, as of January 2017. The Centers for Medicare & Medicaid Services (CMS) administrative data show that CHIP enrollment is concentrated among families with annual income at lower levels. FY2013 state-reported administrative data show that approximately 99.4% of CHIP child enrollees were in families with annual income at or below 300% of FPL. Under the ACA maintenance of effort (MOE) provisions, states are required to maintain their Medicaid programs with the same eligibility standards, methodologies, and procedures in place on the date of enactment of the ACA until January 1, 2014, for adults and through September 30, 2019, for children up to the age of 19 (SSA Section 1902(gg)(2)). The ACA also requires states to maintain income eligibility levels for CHIP children through September 30, 2019, as a condition for receiving payments under Medicaid (SSA Section 2105(d)(3)). The penalty to states for not complying with either the Medicaid or the CHIP MOE requirements would be the loss of all federal Medicaid funds. The MOE requirement affects CHIP Medicaid expansion programs and separate CHIP programs differently. For CHIP Medicaid expansion programs, when federal CHIP funding is exhausted, the CHIP-eligible children in these programs will continue to be enrolled in Medicaid but financing will switch from CHIP to Medicaid. For separate CHIP programs, states are provided with two exceptions to the MOE requirement: (1) states may impose waiting lists or enrollment caps to limit CHIP expenditures, and (2) after September 1, 2015, states may enroll CHIP-eligible children in qualified health plans in the health insurance exchanges. In addition, in the event that a state's CHIP allotment is insufficient to fund CHIP coverage for all eligible children, a state must establish procedures to screen children for Medicaid eligibility and enroll those who are Medicaid eligible. For children not eligible for Medicaid, the state must establish procedures to enroll CHIP children in qualified health plans in the health insurance exchanges that have been certified by the Secretary of the Department of Health and Human Services (HHS) to be "at least comparable" to CHIP in terms of benefits and cost sharing. P.L. 115-120 extended the Medicaid and CHIP MOE requirements for children for four years, from FY2020 through FY2023. However, for this period, the Medicaid and CHIP MOE requirements only apply to children in families with annual income less than 300% of FPL. During this specified period, states are permitted to roll back Medicaid and/or CHIP eligibility for children in families with annual income that exceeds 300% of FPL without the loss of all federal Medicaid matching funds. Section 50101(f) extends the Medicaid (SSA Section 1902(gg)(2)) and CHIP (SSA Section 2105(d)(3)) MOE requirements for children for four years, from FY2024 through FY2027. SSA Section 1139A authorizes a variety of activities related to pediatric quality measurement for health care provided under Medicaid or CHIP. Under SSA Section 1139A(a), the HHS Secretary was required to identify and publish an initial core set of pediatric quality measures by no later than January 1, 2010. SSA Section 1139A(b) required the Secretary to establish a Pediatric Quality Measures Program (PQMP) by January 1, 2011. This program is required to identify pediatric quality measure gaps and development priorities, award grants and contracts to develop measures, and revise and strengthen the core measure set, among other things. Section 1139A(c) requires states to submit reports to the Secretary annually to include information about state-specific child health quality measures applied by the state, among other things. Under Section 1139A(d), the Secretary also was required, between FY2009 and FY2013, to award no more than 10 grants to states and child health providers for demonstration projects to evaluate ideas to improve the quality of children's health care. In addition, the Secretary, not later than January 1, 2010, was required by Section 1139A(f) to establish a program to encourage the development and dissemination of a model electronic health record for children. The Institute of Medicine (IOM) was required under Section 1139A(g) to develop a report on the measurement of child health status and quality by no later than July 1, 2010. Funding for these activities was appropriated in the amount of $45 million for each of FY2009 through FY2013. Section 210 of the Protecting Access to Medicare Act of 2014 (PAMA,  P.L. 113-93 ) extended funding for only the PQMP for FY2014 by requiring that not less than $15 million of the $60 million appropriated for adult health quality measures under SSA Section 1139B(e) for FY2014 be used to carry out Section 1139A(b). The appropriation in Section 1139A(i) for funding to carry out Section 1139A (except for subsection (e)) expired in FY2013; the funding designated to carry out Section 1139A(b) expired in FY2014. MACRA Section 304(b) appropriated $20 million for the period FY2016 through FY2017 for the purposes of carrying out SSA Section 1139A. Section 3003(b) of P.L. 115-120 amended SSA Section 1139A(i) to appropriate funding in the amount of $90 million for the period of FY2018 through FY2023 to be used to carry out the activities of Section 1139A. This funding remains available until expended, and is specifically excluded from being used to carry out the activities under subsections (e), (f), and (g). Section 50102(a) amends SSA Section 1139A(i) to appropriate $60 million for the period of FY2024 through FY2027 to carry out specified pediatric quality measurement activities under the section (excluding subsections (e), (f) and (g)), including maintenance of a pediatric core quality measure set, identification of measure gaps, and development of measures. Section 50102(b) amends SSA Section 1139A subsections (a) and (c) to make annual state reporting to the HHS Secretary of the pediatric core measure set mandatory, beginning with the report on FY2024, and to modify the triennial reporting requirement from the HHS Secretary to Congress to include the status of mandatory reporting by states, beginning with the report required on January 1, 2025. CHIPRA Section 201 appropriated (out of funds in the Treasury that were not otherwise appropriated) $100 million in outreach and enrollment grants for FY2009 through FY2013 to be used by eligible entities (e.g., states, local governments, community-based organizations, elementary and secondary schools) to conduct outreach and enrollment efforts that increase the participation of Medicaid and CHIP-eligible children. Of the total appropriation, 10% is directed to a national campaign to improve the enrollment of underserved child populations, and 10% is targeted to outreach for Native American children. The remaining 80% is distributed among eligible entities for the purpose of conducting outreach campaigns, focusing on rural areas and underserved populations. Grant funds also are targeted at proposals that address cultural and linguistic barriers to enrollment. The ACA appropriated $140 million for FY2009 through FY2015 for outreach and enrollment grants. MACRA Section 303 appropriated $40 million for FY2016 and FY2017 for outreach and enrollment grants. Most recently, P.L. 115-120 amends SSA Section 2113(a)(1) and (g) to appropriate $120 million for CHIP outreach and enrollment grants for the period of FY2018 through FY2023. The provision also adds parent mentors to the list of entities that are eligible to receive outreach and enrollment grants under SSA Section 2113(f). Parent mentors are defined as a parent or guardian of a child who is eligible for Medicaid or CHIP who is trained to assist families with uninsured children to improve social determinants of health. Such assistance may include educating families about how to obtain health insurance coverage, assisting families with completing (and submitting) health insurance coverage applications, serving as a liaison between families and representatives of Medicaid and CHIP, providing guidance to families on identifying medical and dental homes and community pharmacies for children, and providing assistance and referrals to families to address social determinants of children's health (e.g., poverty, food insufficiency and housing). The provision also requires such compensation to be disregarded when determining Medicaid modified adjusted gross income (MAGI)-based income eligibility for individuals acting as parent mentors. Section 50103 amends SSA Section 2113(a)(1) and (g) to appropriate $48 million for CHIP outreach and enrollment grants for the period of FY2024 through FY2027, and requires 10% of such funds to be set aside for use by the HHS Secretary for evaluations and technical assistance. The provision also amends SSA Section 2113(h) to allow reserved national enrollment campaign funds to be used for technical assistance in the development of enrollment and retention strategies for underserved Medicaid and CHIP child populations. SSA Section 501(c) established the Family-to-Family Health Information Centers program, which funds family-staffed and family-run centers in the 50 states and the District of Columbia. The Family-to-Family Health Information Centers provide information, education, technical assistance, and peer support to families of children (including youth) with special health care needs and health professionals who serve such families. In addition, the centers help ensure that families and health professionals are partners in decisionmaking at all levels of care and service delivery. The Health Resources and Services Administration (HRSA) administers this program. The program began in 2005 as part of the Deficit Reduction Act of 2005 (DRA; P.L. 109-171 ). The Family-to-Family Health Information Centers received an annual direct appropriation of $3 million for FY2007, which increased to $5 million for each of FY2009 through FY2017. The program's appropriation was most recently extended in MACRA. Section 50501 amends SSA Section 501(c) to extend funding for the Family-to-Family Health Information Centers program for FY2018 and FY2019 by providing $6 million in each year. It also amends SSA Section 501(c) to require that Family-to-Family Health Information Centers be developed in all of the territories (as defined) and that at least one center be developed for Indian tribes. It defines the terms "Indian Tribe," "State," and "territory." Section 50502 replaces SSA Section 510 with new language. The following provides the background and provision description for each subsection of the new SSA Section 510. The 1996 welfare reform law ( P.L. 104-193 ) established a "Separate Program for Abstinence Education" under SSA Section 510. The program—commonly referred to as the Title V Abstinence Education Grant program—is to fund states and territories in providing abstinence education and (optionally, where appropriate) mentoring, counseling, and adult supervision "with a focus on those groups which are most likely to bear children out-of wedlock." The law does not define such groups. In practice, Abstinence Education funding has been used generally for children in elementary through high school. Section 50502 amends SSA Section 510 by renaming the program as the Sexual Risk Avoidance Education program. As specified in the law, states (including territories) are eligible to request Title V Abstinence Education Grant funds for a given fiscal year if they submit an application for Maternal and Child Health (MCH) Services Block Grant funds for that same fiscal year. The MCH Services Block Grant, authorized under Title V of the Social Security Act, is a flexible source of funds that states use to support maternal and child health programs. Abstinence Education Grant funds are allocated to each jurisdiction based on its relative proportion of low-income children nationally. The FY2015 annual appropriations law ( P.L. 113-235 ) included a provision that enabled HHS to reallocate FY2015 Abstinence Education funds that would have been designated for states that did not apply for the funds. These FY2015 funds were available only to states that had applied for the funds, and states could use them to implement elements described in "abstinence education," as the term is defined in the law. MACRA extended this language to program funding for FY2016 and FY2017. Section 50502 provides that FY2018 and FY2019 Sexual Risk Avoidance Education allotments are to be made to states (and territories) that have applied for MCH Services Block Grant funds. Allotments are based on two factors. First, funding is available based on the amount provided to the program minus any reservations (up to 20%) made by HHS for administering the program. Second, funds are allocated to states based on their relative proportion of low-income children nationally. Further, Section 50502 enables HHS to competitively award FY2018 and FY2019 funds to one or more entities within a state/territory that had not previously applied for its share of funding. The entity or entities would receive the amount that would have been otherwise allotted to that state. The HHS Secretary is required to publish a notice to solicit grant applications for the remaining competitive funds. The solicitation must to be published within 30 days after the deadline for states to apply for MCH Services Block Grant funds. Eligible states are required to apply for the Sexual Risk Avoidance Education funds no later than 120 days after the deadline closed for states to apply for MCH Services Block Grant funds. Title V Abstinence Education Grant funds must be used exclusively for teaching abstinence and may not be used in conjunction with, or for, any other purpose. The law defines the term "abstinence education" as an educational or motivational program that has as its exclusive purpose teaching the social, psychological, and health gains of abstaining from sexual activity; teaches that abstinence from sexual activity outside of marriage is the expected standard for all school-age children; teaches that abstinence is the only certain way to avoid out-of-wedlock pregnancy, sexually transmitted infections (STIs), and associated health problems; teaches that a mutually faithful monogamous relationship within marriage is the expected standard of human sexual activity; teaches that sexual activity outside of marriage is likely to have harmful psychological and physical effects; teaches that bearing children out-of-wedlock is likely to have harmful consequences for the child, the child's parents, and society; teaches young people how to reject sexual advances and how alcohol and drug use increases vulnerability to sexual advances; and teaches the importance of attaining self-sufficiency before engaging in sex. Section 50502 amends SSA Section 510 to specify that Sexual Risk Avoidance Education program funds are available to a state or other entity (in a state that did not apply for funds) to implement education exclusively on sexual risk avoidance, meaning voluntarily refraining from sexual activity. This requirement does not apply to research conducted by the state or other entity or to information that the state or entity may collect under the program. States or other entities are required to implement sexual risk avoidance education that is medically accurate and complete, age-appropriate, and based on adolescent learning and developmental theories for the age group receiving the education. The education must also be culturally appropriate, recognizing the experiences of youth from diverse communities, backgrounds, and experiences. In addition, sexual risk avoidance education must ensure that the "unambiguous and primary emphasis and context" for each of six sexual risk avoidance topics is "a message to youth that normalizes the optimal health behavior of avoiding nonmarital sexual activity." The sexual risk avoidance topics include the following: The holistic individual and societal benefits associated with personal responsibility, self-regulation, goal setting, healthy decisionmaking, and a focus on the future. The advantage of refraining from nonmarital sexual activity in order to improve the future prospects and physical and emotional health of youth. The increased likelihood of avoiding poverty when youth attain self-sufficiency and emotional maturity before engaging in sexual activity. The foundational components of healthy relationships and their impact on the formation of healthy marriages and safe and stable families. How other youth risk behaviors, such as drug and alcohol usage, increase the risk for teen sex. How to resist, avoid, and receive help regarding sexual coercion and dating violence, recognizing that even with consent teen sex remains a youth risk behavior. If sexual risk avoidance education includes any information about contraception, such information must be medically accurate and must help students understand that contraception reduces physical risk but does not eliminate risk. In addition, sexual risk avoidance education may not include demonstration, simulations, or distribution of such contraception devices. Title V of the Social Security Act does not address evaluation activities for the Abstinence Education Grant program; however, the BBA97 directed HHS to conduct evaluation activities of the Title V Abstinence Education program. Section 50502 amends SSA Section 510 to specify that a state or other entity receiving funding under the Sexual Risk Avoidance Education program may use up to 20% of such allotment to build the evidence base for sexual risk avoidance by conducting or supporting research. Any such research must be rigorous, evidence-based, and designed and conducted by independent researchers who have experience in conducting and publishing research in peer-reviewed outlets. A state or other entity that receives Sexual Risk Avoidance Education grants must, as specified by the HHS Secretary, collect information on the programs and activities funded through their allotments and submit reports to HHS on the data collected from such programs and activities. Separately, HHS is required to conduct one or more rigorous evaluations of the education (and associated data) funded through the Sexual Risk Avoidance Education program. This evaluation is to be conducted in consultation with "appropriate State and local agencies." HHS is to consult with relevant stakeholders and evaluation experts about the evaluation(s). HHS must submit a report to Congress on the results of the evaluation(s). The report must also include a summary of the information collected and reported by states and other entities on their Sexual Risk Avoidance Education programs and activities. SSA Section 510 specified that selected sections of the act that apply to allotments made under the MCH Services Block Grant—including SSA Sections 503 (Payments to states), 507 (Criminal penalty for false statement), and 508 (Nondiscrimination)—also applied in the same way to the allotments made under the Abstinence Education program. In addition, the HHS Secretary was able to determine the extent to which other sections, SSA Section 505 (Application for block grant funds) and SSA Section 506 (Reports and audits), also applied to Abstinence Education allotments. Section 50502 specifies that SSA Sections 503, 507, and 508 apply to allotments under the MCH Services Block Grant continue to also apply to allotments under the Sexual Risk Avoidance Education program. HHS continues to have discretion in determining the extent to which the provisions under SSA Sections 505 and 506 apply. SSA Section 510 did not previously include definitions. Section 50502 adds four definitions to SSA Section 510 under the new SSA Section 510(e): "Age-appropriate": suitable (in terms of topics, messages, and teaching methods) to the developmental and social maturity of the particular age or age group of children or adolescents, based on developing cognitive, emotional, and behavioral capacity typical for the age or age group. "Medically accurate and complete": verified or supported by the weight of research conducted in compliance with accepted scientific methods and (1) published in peer-reviewed journals, where applicable; or (2) comprising information that leading professional organizations and agencies with relevant expertise in the field recognize as accurate, objective, and complete. "Rigorous": With respect to research and evaluation, means using (1) established scientific methods for ensuring the impact of an intervention or program model in changing behavior (specifically sexual activity or other risk behaviors), or reducing pregnancy, among youth; or (2) other evidence-based methodologies established by the Secretary for purposes of the Sexual Risk Avoidance Education program. "Youth": One or more individuals aged 10 through 19. The Title V Abstinence Education Grant program has been funded through mandatory funds. P.L. 104-193 provided $50 million to the program per year for five years (FY1998-FY2002). Subsequently, the grant was funded through various extensions of that spending. Most recently, MACRA increased funding for the program to $75 million per year for FY2016 and FY2017. Section 50502 amends SSA Section 510 under the new SSA Section 510(f) to provide $75 million in mandatory funds to the Sexual Risk Avoidance Education program for each of FY2018 and FY2019. The HHS Secretary is required to reserve, for each of these two years, up to 20% of the funding for administering the program. Such administrative funding includes funding for HHS to conduct a national evaluation(s) of the program and provide technical assistance to states that receive funding. Under prior law, the SSA Section 510 provisions were generally applied to grants made through FY2017. Section 50502(b) makes the new program included in Section 50502(a) effective retroactive to the start of FY2018, or October 1, 2017. ACA Section 2953 established the Personal Responsibility Education Program (PREP) under SSA Section 513. The program is a broad approach to teen pregnancy prevention that seeks to educate adolescents aged 10 through 19 and pregnant and parenting youth under age 21 on both abstinence and contraceptives to prevent pregnancy and STIs. The ACA provided $75 million annually in mandatory spending for each of five fiscal years (FY2010 through FY2014). PREP authorization had been most recently extended, by MACRA, for FY2015 through FY2017. All states, the District of Columbia, and all territories are eligible for state PREP funding. Funds are allocated by formula, based on the proportion of youth aged 10 through 19 in each jurisdiction relative to other jurisdictions. If a state or territory did not submit an application for formula funding in FY2010 or FY2011, it was ineligible to apply for funding for each of FY2010 through FY2017. Local organizations, including faith-based organizations or consortia, in such a state or territory were eligible to competitively apply for funding. The law specifies that funding is to be provided as three-year grants to carry out programs and activities that would have otherwise been carried out by the state. In practice, HHS refers to these "3-Year Grants" (per the law) as Competitive PREP grants. HHS also provides PREP grants to Indian tribes and tribal organizations (known as Tribal PREP), as well as grants to implement innovative strategies (known as PREIS, or Personal Responsibility Education Program Innovative Strategies). Tribal PREP grants are intended to support projects that educate American Indian and Alaska Native youth, including pregnant and parenting youth, on both abstinence and contraceptives to prevent pregnancy and STIs. PREIS grants are intended to build evidence on promising teen pregnancy prevention programs for high-risk, vulnerable, and culturally underrepresented youth populations. The law specifies that these populations include youth aged 10 to 20 in foster care, homeless youth, youth with HIV/AIDS, pregnant and parenting women who are under 21 years of age and their partners, and youth residing in areas with high birth rates for youth. Section 50503 amends SSA Section 513 to provide $75 million for PREP in each of FY2018 and FY2019. It specifies that the competitive "3-Year Grants" are now referred to in law as "Competitive PREP Grants." Further, it extends the requirement that states are not eligible to submit an application for funding, through FY2019, if they did not submit an application in FY2010 and FY2011. The Competitive PREP grants that were awarded for any of FY2015 through FY2017 in such states are to continue for an additional two years, through FY2019. In addition, it specifies that victims of human trafficking are considered high-risk, vulnerable, and culturally underrepresented youth for purposes of the PREIS program. The amendments are retroactively effective as of October 1, 2017.  ACA Section 5507(a) required the HHS Secretary to establish a demonstration project in SSA Section 2008 to award funds to states, Indian tribes, institutions of higher education, and local workforce investment boards for health profession opportunity grants (HPOG). These grants were used to help low-income individuals—including individuals receiving assistance from state Temporary Assistance for Needy Families programs—to obtain education and training in health care jobs that pay well and are in high demand. Funds also are used to provide financial aid and other supportive services. This program is administered jointly by HRSA and ACF. The ACA provided $85 million in mandatory funding for HPOG in each of FY2010-FY2014 ($425 million total), but a total of $15 million was reserved for a demonstration project for personal and home care aides. The program's funding has been extended twice, most recently in MACRA, which provided $85 million for each of FY2016 and FY2017. This section amends SSA Section 208(c)(1) to extend HPOG funding through FY2019. Specifically, the provision provides $85 million in mandatory funding for the program for each of FY2018 and FY2019. The health center program, authorized by Section 330 of the Public Health Service Act (PHSA), provides grants to not-for-profit or state and local government entities to operate outpatient health centers. These centers are required to be located in medically underserved areas (MUAs) or to provide care to a population that is designated as underserved. Historically, the health center program had generally been supported with discretionary appropriations; however, in 2010, the ACA created the Community Health Center Fund (CHCF), which provided mandatory funding for the program. The ACA appropriated a total of $9.5 billion to the fund from FY2011 through FY2015, as follows: $1 billion for FY2011, $1.2 billion for FY2012, $1.5 billion for FY2013, $2.2 billion for FY2014, and $3.6 billion for FY2015. Mandatory funding for the CHCF was subsequently extended as part of MACRA, which provided $3.6 billion for each of FY2016 and FY2017. The mandatory CHCF appropriations are provided in addition to discretionary funding for the program; however, the CHCF comprised approximately 72% of health center programs' appropriations in FY2017. At the start of FY2018, no funds were appropriated for the CHCF; funding was later provided in P.L. 115-96 (Division C—Health Provisions of the Further Additional Continuing Appropriations Act, 2018), which provided $550 million for the first two quarters of FY2018. Section 50901(a) amends ACA Section 10503(b)(1)(F) to replace language included in P.L. 115-96 with a longer extension of the CHCF's mandatory funding. Specifically, it provides $3.8 billion for the CHCF for FY2018 and $4.0 billion for FY2019. PHSA Section 330 health center grants are awarded competitively, with some preference given to sites in rural areas. The program has a number of grant programs, including, but not limited to, grants to support health center operations, grants to enable health centers to expand services, and grants for health centers to engage in quality improvement activities. The health center program supports four types of health centers: (1) community health centers, (2) health centers for the homeless, (3) health centers for residents of public housing, and (4) migrant health centers. Community health centers (CHCs) are the most numerous because they provide care to a generally underserved population. The remaining three types are less common because each serves more targeted subpopulations of the underserved than do CHCs. All four types of health centers are required to provide primary health services and preventive and emergency health services. Primary health services are those provided by physicians or physician extenders (physicians' assistants, nurse practitioners, and nurse midwives) to diagnose, treat, or refer patients. Primary health services include relevant diagnostic laboratory and radiology services. Preventive health services include well-child care, prenatal and postpartum care, immunization, family planning, health education, and preventive dental care. Emergency health services refer to the requirement that health centers have defined arrangements with outside providers for emergent cases that the center is not equipped to treat and for after-hours care. Health centers are also required to provide additional health services that are not primary health services but are necessary to meet the health needs of the service population. This includes, but is not limited to, behavioral health services and environmental health services. Section 50901(b) amends PHSA Section 330 to make a number of changes to the health center program. It modifies references to "substance abuse" to "substance use disorder" throughout the authorization of the health center program in PHSA Section 330. It deletes the authorization for a number of health center grant programs that are no longer operational. Specifically, it deletes authorizations of grants for (1) Managed Care Network and Plans and (2) Practice Management Networks. It also strikes language that specified how funds under those grants programs could be used, and it makes conforming changes throughout the section to remove reference to "plans." The subsection makes a number of changes to grant programs authorized in PHSA Section 330 as follows. Grants for Evidence-Based Models Section 50901(b) eliminates an existing loan guarantee program and replaces the existing language with language that authorizes the HHS Secretary to make supplemental funding awards to existing centers to implement evidence-based models for improving access to high-quality primary care services. Evidence-based models include models related to improving the delivery of care for individuals with multiple chronic conditions, altering workforce configurations, reducing the cost of care, enhancing care coordination, expanding the use of telehealth, integrating primary care and behavioral health services, and addressing emerging public health or substance use disorder issues. The provision also authorizes the Secretary, when making these new supplemental grant awards, to consider whether the applicant health center has submitted a plan for continuing the proposed quality improvement activities after the supplemental funding award has ended. The subsection also authorizes the Secretary to give special consideration to applications for supplemental activities that seek to address significant barriers to access to care in areas where provider shortages are greater than the national average. Operating Grants Subsection 50901(b) makes the following changes to the operating grant program in PHSA Section 330(e)(1). First, it shortens the award period from two years to one year for entities that are unable to comply with all of the health center program requirements. It also prohibits the HHS Secretary from making an operating grant to a noncompliant center unless the applicant can provide assurance that within 120 days of receiving grant funding it will submit an implementation plan to meet the health center program's requirements. The subsection also permits the Secretary to extend the 120-day period if the health center demonstrates good cause. Second, the subsection adds language to permit operating grant funds to be used to purchase (1) data and information systems; (2) training and technical assistance; and (3) other activities that aim to reduce the costs associated with providing health services, improve health care access, enhance the quality and coordination of services that health centers provide, and improve the health status of communities. New Access Points Grants Section 50901(b) adds a new PHSA Section 330(e)(6) related to grants for "New Access Points and Expanded Services." PHSA Section 330(e)(6)(A) permits the HHS Secretary to make these grants to health centers to establish new delivery sites and adds language giving special consideration to applicants that demonstrate that the new delivery site will be located in either a sparsely populated area or an area with a high level of unmet need relative to other applicants. The provision also specifies that when making these awards, the Secretary is required to ensure that the ratio of awards to health centers that serve rural populations relative to those that serve urban populations is not less than a two-to-three ratio or greater than a three-to-two ratio. The provision also authorizes the Secretary to consider when making grants where an applicant for a new delivery site would overlap the catchment area of an existing delivery site, and whether such overlap is justified based on the unmet needs of the population that the applicant proposes to serve (i.e., its catchment area). Expanded Service Grants Section 50901(b) adds new language in PHSA Section 330(e)(6)(B) related to approving expanded service applications. It authorizes the HHS Secretary to approve applications for grants that would expand the capacity of health centers to provide required primary health services or additional services. It also authorizes the Secretary to give special consideration to applicants that propose to expand services to address emerging public health or behavioral health issues through increasing the availability of additional health services in areas in which there are significant barriers to accessing care. The provision also specifies that when making these awards, the Secretary is required to ensure that the ratio of awards to health centers that serve rural populations relative to those that serve urban populations is not less than a two-to-three ratio or greater than a three-to-two ratio. Health Centers for the Homeless Section 50901(b) also amends PHSA Section 330(h) to add language specifying that grants for Health Centers for the Homeless include homeless veterans and veterans at risk of homelessness in their target service population. Health Center Grant Applications Section 50901(b) amends PHSA Section 330(k), related to health center application requirements, to specify that applicants describe the unmet health services needs of their service areas. In addition, the provision requires that applicants demonstrate that they have consulted with appropriate state and local government agencies and health care providers regarding the need for health services at the proposed delivery site. It amends the HHS Secretary's requirements when approving a grant to broaden the requirements associated with assessing whether the health center has made efforts to establish relationships with health care providers in its catchment area. Specifically, it adds language that requires the Secretary to consider whether the health center has made efforts to collaborate with other health care providers in its catchment areas, including local hospitals and specialty providers, with the goal of increasing collaboration with these providers to reduce the nonurgent use of hospital emergency departments for nonurgent conditions. Health Center Governance, Technical Assistance, and Auditing Requirements Section 50901(b) amends various PHSA Section 330 subsections. Specifically, it amends language regarding a health center's governing board to specify that it must approve the health center director, who is required to be directly employed by the center, and adds new language requiring the health center to have in place written policies to ensure the appropriate use of federal funds, in accordance with applicable federal statute, regulations, and the terms and conditions of the federal grant. It restricts the funds available for technical assistance and operational support activities to an amount that shall not exceed 3% of the funds appropriated for this section in a given fiscal year. It restricts the HHS Secretary's authority to waive a health center's auditing requirements to one year without the ability to extend the waiver into the next consecutive year. Health Center Reporting Section 50901(b) amends PHSA Section 330(r)(3) to specify which congressional committees would receive the required health center funding report and adds new reporting requirements, including (1) funding distribution by geography and grant types, (2) information on unexpended funding and funding for loan guarantees authorized in PHSA Title XVI, and (3) information on health center closures, among others. Health Center Research Project Participation Section 50901(b) adds a new PHSA Section 330(r)(5) that appropriates $25 million for FY2018 to support the participation of health centers in the "All of Us Research Program," part of the Precision Medicine Initiative (PMI) under PHSA Section 498E. The subsection specifies that the funding is in addition to (1) funds made available to the CHCF under this provision, (2) funds previously made available to the CHCF, and (3) funds made available to the National Institutes of Health. Individualized Wellness Plans Section 50901(b) deletes PHSA Section 330(s), which had authorized grants for a pilot program to develop individualized wellness plans at not more than 10 CHCs. The CHCF also provides mandatory funding for the National Health Service Corps (NHSC), authorized in Title III of the PHSA. The NHSC provides scholarships and loan repayments to certain health professionals in exchange for providing care in a health professional shortage area (HPSA) for a period of time that varies based on the length of the scholarship or the number of years of loan repayment received. This program last received discretionary appropriations in FY2011; since that time, CHCF funds have been the sole source of NHSC funding. At the start of FY2018, no funds were appropriated for the CHCF; funding was later provided in P.L. 115-96 (Division C—Health Provisions of the Further Additional Continuing Appropriations Act, 2018), which provided $65 million for the first two quarters of FY2018. Section 50901(c) amends ACA Section 10503(b)(2)(F) to replace language included in P.L. 115-96 to extend mandatory funding for the NHSC funding for a longer time period. Specifically, it provides $310 million for each of FY2018 and FY2019. PHSA Section 340H provides direct and indirect graduate medical education (GME) payments to support medical and dental residents training at qualified teaching health centers, which are outpatient health care facilities that provide care to underserved patients. ACA Section 5508(c) created and provided $230 million in mandatory funding for the Teaching Health Center Graduate Medical Education Program (THCGME) for the period of FY2011 through FY2015. Program funding was subsequently extended in MACRA, which appropriated $60 million for each of FY2016 and FY2017 for direct and indirect GME payments for teaching health centers. MACRA funds were used to fund residents at existing teaching health center programs; no new teaching health centers were added to the program. FY2018 funding has been provided in two laws that each provided one-quarter of funding; specifically, funding for the first quarter of FY2018 was provided by the Disaster Tax Relief and Airport and Airway Extension Act of 2017 ( P.L. 115-63 ), which provided $15 million for the first quarter of FY2018, and in P.L. 115-96 (Division C—Health Provisions of the Further Additional Continuing Appropriations Act, 2018), which struck the $15 million that had been provided for the first quarter of FY2018 and appropriated $30 million for the first two quarters of FY2018. Section 50901(d) amends PHSA Section 340H to make several changes to the THCGME. It permits payments to be made to support the residency training of (1) the current number of trainees in existing programs, (2) new residents trained in existing programs, and (3) new residents training in new programs. When making payments under this section, the HHS Secretary is required to consider the costs of training residents at teaching health centers and the implications of the per-resident amount on approved graduate medical residency training programs at Teaching Health Centers. With regard to newly established residency programs, the provision gives funding preference to programs in HPSAs/MUAs or programs located in rural areas. The provision strikes the $30 million provided for the first two quarters of FY2018 and instead provides $126.5 million for each of FY2018 and FY2019, to remain available until expended. The subsection amends PHSA Section 340H(h) to modify the program's reporting requirements to require additional data on (1) the volume of care provided by residents supported under the program and (2) the number and percentage of graduated residents who enter into primary care practice and the number and percentage of graduated residents who do so in an HPSA, MUA, or a rural area. The provision also requires that the HHS Secretary submit a report to Congress not later than March 31, 2019, on the direct and indirect expenses associated with the additional costs of teaching residents at teaching health centers. It defines the term "new approved graduate medical residency training program" and specifies that the requirements for THCGME that were in effect prior to enactment will remain in effect with respect to THCGME payments made for fiscal years prior to FY2018. Under federal law, federal funds are generally not available to pay for abortions, except in cases of rape, incest, or endangerment of a mother's life. This restriction is the result of statutory and legislative provisions like the Hyde Amendment, which has been added to the annual appropriations measure for HHS since 1976. This prohibition was most recently included in the Consolidated Appropriations Act, 2017 ( P.L. 115-31 ). Section 50901(e) applies existing restrictions on the use of funds for abortions (included in the Consolidated Appropriations Act, 2017 [ P.L. 115-31 ]) to funds appropriated by this act to health centers, the NHSC, and qualified teaching health centers for FY2018 and FY2019. The Justice for Victims of Trafficking ( P.L. 114-22 ) permitted that between $5 million and $30 million of funds appropriated to the CHCF could be transferred to the Department of Justice (DOJ) to be used for health services for victims of human trafficking. Section 50901(f) amends 18 U.S.C. 3014(h) to continue the authority for HHS to transfer funds to DOJ for victims of human trafficking for the time period of the CHCF funding extension (i.e., FY2018 and FY2019). PHSA Section 330 B authorizes the Special Diabetes Program for Type I Diabetes that provides funding for the National Institutes of Health (NIH) to award grants for research into the prevention and cure of type I diabetes. PHSA Section 330C authorizes the Special Diabetes Program for Indians, which provides funding for the Indian Health Service (IHS) to award grants for services related to the prevention and treatment of diabetes for American Indians and Alaska Natives who receive services at IHS-funded facilities. These programs were created in the BBA97, which transferred $30 million annually from CHIP funds to each program from FY1998 through FY2002. The program's funding was extended and increased in subsequent legislation. For example, MACRA provided $150 million for each program for each of FY2016 and FY2017. These programs had been funded in tandem; however, the Special Diabetes Program for Indians received $37.5 million in the Disaster Tax Relief and Airport and Airway Extension Act of 2017 P.L. 115-63 ) for the first quarter of FY2018 while no funding was provided for the Special Diabetes Program for Type I Diabetes. Both programs were later provided with funding in P.L. 115-96 (Division C—Health Provisions of the Further Additional Continuing Appropriations Act, 2018), which provided $37.5 million for the first and second quarters of FY2018 for the Special Diabetes Program for Type 1 Diabetes and $37.5 million for the second quarter of FY2018 for the Special Diabetes Programs for Indians. Section 50902 amends PHSA Section 330B and PHSA Section 330C to replace the funding language included in P.L. 115-96 with new language that provides longer funding extensions for the two Special Diabetes Programs. Specifically, it provides $150 million in mandatory funding for each of FY2018 and FY2019 for the Special Diabetes Program for Type I Diabetes and amends PHSA Section 330C to provide $150 million in mandatory funding for each of FY2018 and FY2019 for the Special Diabetes Program for Indians. Funds for both programs are to remain available until expended. ACA Section 4002 established the Prevention and Public Health Fund (PPHF), to be administered by the HHS Secretary, and provided it with a permanent annual appropriation. The PPHF is intended to support an "expanded and sustained national investment in prevention and public health programs. " In general, PPHF funds have been distributed to HHS agencies in the Public Health Service, in particular the Centers for Disease Control and Prevention. Amounts for each fiscal year are available to the HHS Secretary beginning October 1, the start of the respective fiscal year. Congress may explicitly direct the distribution of PPHF funds and did so for FY2014 through FY2018. Under the ACA, the PPHF's annual appropriation would increase from $500 million for FY2010 to $2 billion for FY2015 and each subsequent fiscal year. BBA 2018 marks the fourth time Congress has reduced PPHF appropriations since then, using a portion of the Fund as an offset for the costs of other activities. Section 53119 amends ACA Section 4002 to repeal $1.35 billion in appropriations to the PPHF for FY2019 through FY2027. It redistributes funds over that period, with increased appropriations for FY2019 through FY2021, and decreased appropriations across the later fiscal years. Annual appropriations to the PPHF in current law, reflecting BBA 2018, are as follows: $500 million for FY2010, $1.0 billion for each of FY2012 through FY2017, $900 million for each of FY2018 and FY2019, $950 million for each of FY2020 and FY2021, $1.0 billion for each of FY2022 and FY2023, $1.3 billion for each of FY2024 and FY2025, $1.8 billion for each of FY2026 and FY2027, and $2.0 billion for FY2028 and each fiscal year thereafter. ACA Section 2951 established the MIECHV program at SSA Section 511. It provides grants to states, territories, and tribes ("eligible entities") for the support of evidence-based early childhood home visiting. Home visiting entails in-home visits by health or social service professionals with at-risk families. The program is funded through mandatory spending. The ACA provided a total of $1.5 billion for FY2010 through FY2014 for the home visitation grant program. Subsequently, the program was funded through various extensions of that funding. Most recently, MACRA had increased funding for the program to $400 million annually for FY2016 and FY2017. Section 50601 amends SSA Section 511(j) to provide mandatory funding of $400 million for the MIECHV program for each of FY2017 through FY2022. Eligible entities must establish, subject to approval of the HHS Secretary, quantifiable and measurable benchmarks for demonstrating improvements for eligible families participating in the program in each of six areas: (1) improved maternal and newborn health; (2) prevention of child injuries, child abuse, neglect, or maltreatment, and reduction of emergency department visits; (3) improvements in school readiness and achievement; (4) reduction in crime or domestic violence; (5) improvements in family economic self-sufficiency; and (6) improvements in the coordination and referrals for other community resources and supports. Performance in the benchmark areas is to be assessed at three and five years following the start of program. Each eligible entity is required to submit a report to the HHS Secretary demonstrating that it has made improvements in at least four of the six benchmark areas during the first three years that it carries out the program. The report is to be submitted within 30 days of the end of that three-year period. An eligible entity must submit, as part of its grant application to HHS, the quantifiable and measurable benchmarks it has established to demonstrate that the program contributes to improvements for eligible families in the six areas. If an eligible entity fails to demonstrate improvements in four of the six benchmark areas within the first three years of program implementation, it must develop and implement a plan to make improvements in each of the applicable benchmark areas, subject to approval by the HHS Secretary. The improvement plan must include provisions for the HHS Secretary to monitor the plan's implementation and conduct continued oversight of the program, including by regular reports submitted by the eligible entity. The Secretary must provide technical assistance—directly or through grants, contracts, or cooperative agreements—to the eligible entity in developing and implementing the plan to address improvements after the initial three years. The HHS Secretary must convene an advisory panel made up of staff from HHS and the Department of Education to make recommendations about this technical assistance. The HHS Secretary must terminate an eligible entity's MIECHV funding if, after a period of time specified by the Secretary, the eligible entity has not made improvements in at least four of the benchmark areas during the first three years of the program's implementation; or if the Secretary determines that the eligible entity has failed to submit the required report on performance in the benchmark areas after that initial three-year period. The Secretary may include any unexpended grant funds in grants made to nonprofit organizations that operate home visiting programs in states that had not (as of the beginning of FY2012) applied or been approved for a MIECHV grant. Section 50602 amends SSA Section 511(d) to direct eligible entities to continue tracking and reporting, subject to the approval of the HHS Secretary, information demonstrating that the program results in improvements for participating families in at least four of the benchmark areas. These four or more benchmark areas include those that the service delivery model(s), as selected by the eligible entity, intends to improve. Specifically, the improvements are to be based on a comparison between enrolled families and eligible families who do not receive services under a home visiting program. Eligible entities are required to track the benchmarks and report on them within 30 days after the end of FY2020 and every three subsequent years. In addition, Section 50602 amends SSA Section 511(e)(f) to require eligible entities to continue submitting this information as part of their grant application; however, the information must pertain to the four or more benchmark areas that the service delivery model(s) intends to improve. If improvements are not made within each three-year period, an eligible entity is required to develop and implement a plan to make improvements in each of the benchmark areas (subject to approval by the HHS Secretary) applicable to the service delivery model(s) selected by the entity. The improvement plan must include the same provisions that have been required under preexisting law. The Secretary is required to continue providing technical assistance, in the same manner as in preexisting law, to the eligible entity in developing and implementing the improvement plan. (Note: The provision does not address the ongoing role of the advisory panel.) HHS may terminate funding for an eligible entity that (1) does not continue to demonstrate ongoing improvements in at least four of the benchmark areas (after a period of time specified by the Secretary) that the service model(s), as selected by the eligible entity, intends to improve, or (2) has failed to submit the required reporting to the HHS Secretary on improvements made in the benchmark areas. As a condition of receiving funds under the MCH Services Block Grant for FY2011, states were required to conduct a statewide needs assessment for the MIECHV program. The statewide needs assessment has three purposes, as outlined in the law: Identify communities with concentrations of premature birth, low-birth weight infants, and infant mortality, including infant death due to neglect or other indicators of at-risk prenatal, maternal, newborn, or child health; poverty; crime; domestic violence; high school dropouts; substance abuse; unemployment; or child maltreatment. Determine the quality and capacity of existing programs or initiatives for early childhood home visitation in the jurisdiction, including the number and types of individuals and families receiving services under such programs or initiatives; gaps in early childhood home visitation in the jurisdiction; and the extent to which such programs and initiatives are meeting the needs of eligible families. Determine the state's capacity for providing substance abuse treatment and counseling services to individuals and families in need of such treatment or services. The needs assessment was to be separate from the statewide needs assessment required under the MCH Services Block Grant. Section 50603 amends SSA Section 511(b)(1) to direct eligible entities to conduct another statewide needs assessment as a condition of receiving funds under the MCH Services Block Grant. The assessment must be coordinated with the statewide needs assessment required under the Maternal and Child Health Services Block Grant, but may be conducted separately. The assessment must be reviewed and updated by the eligible entity no later than October 1, 2020. Eligible entities must give priority for providing home visiting services to specified high-risk populations, including eligible families that (1) reside in communities in need of home visiting services, as identified in the statewide needs assessment; (2) are low-income; (3) include pregnant women under age 21; (4) have a history of child abuse or neglect or have had interactions with child welfare services; (5) have a history of substance abuse or need substance abuse treatment; (6) have users of tobacco products in the home; (7) have children with low student achievement; (8) have children with developmental delays or disabilities; or (9) include individuals who are, or were, serving in the Armed Forces, including families with members who have multiple deployments outside of the United States. Section 50604 amends SSA Section(d)(4)(A) to allow eligible entities to take into account additional factors—staffing, community resource, and other requirements of the service delivery model(s)—that are necessary for the model to operate and demonstrate improvements for high-risk families identified in the needs assessment. SSA Section 511 did not previously address a pay-for-outcomes initiative. Section 50605 amends SSA Section 511(c) to enable eligible entities to use up to 25% of its MIECHV funding for outcomes or success-based payments related to a pay-for-outcomes initiative that satisfies the requirements for providing evidence-based home visiting services. "Pay for outcome initiative" is defined as a performance-based grant, contract, or cooperative agreement awarded by a public entity in which a commitment is made to pay for improved outcomes that result in social benefit and direct cost savings or cost avoidance to the public sector. Such an initiative is to include a feasibility study that describes how the proposed intervention is based on evidence of effectiveness; a rigorous third-party evaluation that uses experimental or quasi-experimental design, or other research methodologies, that allow for the strongest possible causal inferences to determine whether the initiative has met its proposed outcomes; an annual, publicly available report on the progress of the initiative; a requirement that payments are made to the recipient of a grant, contract, or cooperative agreement only when agreed upon outcomes are achieved, except that this requirement does not apply to payments for the third-party evaluation. Funding for pay-for-outcomes initiatives could be expended by the eligible entity for up to 10 years after the funds are made available. (With the exception of this provision, eligible entities have two fiscal years to expend MIECHV funds.) SSA Section 511 did not previously address data exchange standards. Section 50606 amends SSA Section 511(h) to require the head of the department or agency responsible for the MIECHV program (i.e., HRSA and ACF), per SSA Section 511(h), to designate data exchange standards for necessary categories of information that a state agency operating a home visiting program is required to exchange with another state agency under federal law. These standards are to be developed in consultation with an interagency workgroup established by the Office of Management and Budget (OMB) and considering the perspectives of states. To the extent practicable, the data exchange standards must be nonproprietary and interoperable and incorporate standards developed and maintained by three groups of stakeholders: (1) an international voluntary consensus standards body, as defined by OMB; (2) intergovernmental partnerships, such as the National Information Exchange Model; and (3) federal entities with authority over contracting and financial assistance. Also in consultation with OMB, and considering the perspectives of state governments, the provision directs HRSA and ACF to designate data exchange standards to govern federal reporting and data exchanges required under federal law. To the extent practicable, the data exchange standards must (1) incorporate features that are widely accepted, nonproprietary, and searchable, and are in computer-readable format (such as the eXtensible Markup Language); (2) be consistent with and implement applicable accounting principles; (3) be implemented in a manner that is cost-effective and improves program efficiency and effectiveness; and (4) be capable of being continually upgraded as necessary. The provision includes a rule of construction to specify that changes in existing data standards for federal reporting do not require a change to standards that HHS finds to be effective and efficient. The provision goes into effect two years after the law's enactment. Prior law did not address how funds are to be allocated under the MIECHV program. In practice, HHS distributes MIECHV funds by both formula and competitive grants to states and other jurisdictions. The formula awards are based, in part, on relative rates of poverty among children under age five. Poverty data are not applied for the territories because of a general lack of federal poverty data for those jurisdictions; however, federal poverty data are available for Puerto Rico. The territories have received $1 million each in formula funds annually. Section 50607 amends SSA Section 511(j) to direct the HHS Secretary to use the most accurate federal population and poverty data available for each eligible entity if funds are awarded using these data. SSA Section 1923 requires states to make Medicaid DSH payments to hospitals treating large numbers of low-income patients. This provision was intended to recognize the disadvantaged financial situation of those hospitals because low-income patients are more likely to be uninsured or Medicaid enrollees. Hospitals often do not receive payment for services rendered to uninsured patients, and Medicaid provider payment rates generally are lower than the rates paid by Medicare and private insurance. Whereas most federal Medicaid funding is provided on an open-ended basis, federal Medicaid DSH funding is capped. Each state receives an annual DSH allotment, which is the maximum amount of federal matching funds that each state is permitted to claim for Medicaid DSH payments. Each state's Medicaid DSH allotment increases annually by the percentage change in the Consumer Price Index for All Urban Consumers for the prior fiscal year. The ACA reduced the number of uninsured individuals in the United States through its health insurance coverage provisions. Built on the premise that with fewer uninsured individuals there should be less need for Medicaid DSH payments, the ACA included a provision directing the HHS Secretary to make aggregate reductions in Medicaid DSH allotments for FY2014 through FY2020. However, multiple subsequent laws amended the reductions. Under prior law, the aggregate reductions to the Medicaid DSH allotments totaled $43 billion and were to affect allotments for FY2018 through FY2025. After FY2025, allotments would have been calculated as though the reductions never occurred, which means the allotments would have to include the inflation adjustments for the years during the reductions. Section 53101 further amends the Medicaid DSH reductions under SSA Section 1923(f)(7) by eliminating the reductions for FY2018 and FY2019 and increasing the annual reduction amounts for FY2021 through FY2023. The aggregate reduction amounts increase from $43.0 billion to $44.0 billion. Specifically, under this provision, the annual aggregate reductions to the Medicaid DSH allotments are $4.0 billion in FY2020 and $8.0 billion for each year from FY2021 through FY2025. In FY2026, states' DSH allotments will be calculated as though the reductions never occurred, with the annual inflation adjustments for FY2020 through FY2025. Under SSA Section 1902(a)(25), Medicaid generally serves as the payer of last resort. This means that Medicaid will pay for services only to the extent that third parties are not liable. This principle is referred to as third-party liability (TPL). States must collect information concerning TPL at the time of Medicaid eligibility determinations and redeterminations. When an enrollee is entitled to payment by a third party for an item or service but Medicaid has already paid, the enrollee is considered to have assigned his or her claim to payment to the state. Under SSA Section 1902(a)(25)(I)(i), states must, through state law, require health insurers to provide to the state, upon request, coverage information concerning Medicaid enrollees or Medicaid-eligible individuals. At state option, the same requirements can be imposed on health insurers with respect to CHIP enrollees or CHIP-eligible individuals. Under the federal Medicaid regulations, states must require providers to bill liable third parties before billing Medicaid. (This requirement is referred to as cost avoidance. ) SSA Sections 1902(a)(25)(E) and (F) provide for exceptions to the cost-avoidance rule. Specifically, for (1) preventive pediatric services and prenatal services (subparagraph (E)) and (2) services rendered to individuals on whose behalf child support enforcement is being carried out (subparagraph (F)), states are required to pay providers' claims under standard claims payment rules and then seek reimbursement from liable third parties, rather than withholding payment until the third party's liability has been determined. Section 202 of the Bipartisan Budget Act of 2013 (BBA 13; P.L. 113-67 , Division A) made two sets of amendments to Medicaid TPL rules under SSA Section 1902(a)(25). First, BBA 13 Section 202(a) limited the exceptions to the Medicaid TPL requirement of cost avoidance in SSA Section 1902(a)(25)(E) and (F). For preventive pediatric and prenatal services, states may choose to defer payment to providers until 90 days after the date the provider submitted a claim to the third party relating to the services. However, for services to children on whose behalf child support enforcement is being carried out, states must pay a claim under normal claims payment rules if the third party has not paid the provider within 90 days after the provider submitted a claim to the third party, and states may choose to limit the payment delay to 30 days if they determine it is cost-effective and necessary to ensure access to care. Second, BBA 13 Section 202(b) amended the SSA to enable states to recover all portions of TPL payments, such as judgments and liability settlements, received by Medicaid enrollees and clarified that states may impose liens against Medicaid enrollees' assets obtained as part of a judgment or liability settlement. The BBA 13 provisions, as amended by PAMA and MACRA, took effect on October 1, 2017. Section 53102 makes various changes to the TPL rules in SSA Section 1902(a)(25). Section 53102(a) amends SSA Section 1902(a)(25)(E), effective upon enactment, so that the cost-avoidance exception described in that subparagraph applies only to preventive pediatric services and not to prenatal services. Section 53102(b) repeals and delays the TPL changes made by BBA 13. The amendments made by BBA 13 Section 202(b), relating to states' recovery of TPL payments to Medicaid beneficiaries, which took effect on October 1, 2017, are repealed retroactively effective September 30, 2017, so that it is as if they never took effect. The effective date of the amendments made by BBA 13 Section 202(a) to SSA Section 1902(a)(25)(E) and (F), narrowing the TPL cost avoidance exceptions, is delayed by two years, so that those provisions will take effect on October 1, 2019. The repeal and amendment of the BBA 13 Section 202 provisions take effect retroactively, as if enacted on September 30, 2017, and apply with respect to any open claims, including claims pending, generated, or filed, after that date. Section 53102(c) requires the Comptroller General of the United States to submit a report to the House Committee on Energy and Commerce and the Senate Finance Committee not later than 18 months after the date of enactment of BBA 2018 addressing the TPL changes involved in the removal of the cost-avoidance exception for prenatal services at SSA Section 1902(a)(25)(E) (Section 53102(a)(1)) and the delay in the effective date of the BBA 13 amendments relating to the cost avoidance exceptions at SSA Section 1902(a)(25)(E) and (F) (Section 53102(b)(2)). The report should examine (1) the actual or potential impact of the provisions on access to prenatal services, preventive pediatric services, and services to children on whose behalf while support enforcement is being carried out; and (2) the actual or potential impact on providers of payment delays resulting from the provisions. Section 53102(d) amends SSA Section 2107(e) to list the TPL requirements at SSA Section 1902(a)(25) as a Medicaid provision binding on the CHIP program. In addition, subsection (d) amends SSA Section 1902(a)(25)(I)(i) to make it mandatory (rather than optional) for states to require health insurers to respond to coverage queries concerning CHIP enrollees and CHIP-eligible individuals. The ACA created Section 36B of the Internal Revenue Code (IRC) to provide premium assistance tax credits for individuals to purchase coverage through the health insurance exchanges, among other purposes. Section 36B includes a definition of household income, based on MAGI. Section 36B's definition of MAGI is used to determine eligibility for various federal health programs, including Medicaid. As of January 1, 2014, MAGI rules are used in determining eligibility for most of Medicaid's nonelderly populations, including the ACA Medicaid expansion. Medicaid's MAGI income-counting rule is set forth in law and regulation. Under the Medicaid MAGI counting rules, the state looks at each individual's MAGI, deducts 5%, which the law provides as a standard disregard for individuals at the highest income limit for coverage, and compares that income to the income standards set by the state in coordination with CMS. For Medicaid, MAGI is defined as the IRC's adjusted gross income (AGI, which reflects a number of deductions, including trade and business deductions, losses from sale of property, and alimony payments) increased by certain types of income (e.g., tax-exempt interest income received or accrued during the taxable year and the nontaxable portion of Social Security benefits). In addition, under Medicaid regulations, certain types of income are subtracted (e.g., certain scholarships and fellowships) to arrive at MAGI. Also under Medicaid regulations, irregular income received as a lump sum (e.g., state income tax refund, lottery or gambling winnings, one-time gifts or inheritances) is counted as income only in the month received. In addition to specifying the types of household income that must be considered during eligibility determinations, the regulations also define "household." The income of any person defined as a part of an individual's "household" must be counted when determining that individual's income level for purposes of a Medicaid eligibility determination. Medicaid program regulations make a distinction with regard to the budget period when determining income eligibility for applicants and new enrollees as compared to eligibility redeterminations for current enrollees. Specifically, income eligibility for applicants and new enrollees is based on current monthly household income. When redetermining eligibility for current Medicaid enrollees, states are permitted to use current monthly income and family size, or projected annual income and family size for the remaining months of the calendar year. For states that choose the latter measure when redetermining eligibility, Medicaid requires the applicant to predict income and household size for the remaining months of the calendar year. Section 53103 amends SSA Section 1902(a)(17) to require states to consider "qualified lottery winnings" and/or "qualified lump sum income" received by an individual on or after January 1, 2018, when determining eligibility for Medicaid based on MAGI for each such individual. Such income is not counted as household income when determining Medicaid eligibility for other members of the individual's household. Winnings and/or income in an amount less than $80,000 are considered in the month that such winnings and/or income are received. Amounts greater than or equal to $80,000 but less than $90,000 are prorated over a period of two months. Amounts greater than or equal to $90,000 but less than $100,000 are prorated over a period of three months. For purpose of prorating winnings and/or income in amounts greater than or equal to $100,000, one additional month is added for each increment of $10,000 received, not to exceed 120 months (or 10 years) for winnings and/or income of $1,260,000 or more. Winnings and/or income greater than or equal to $80,000 are counted in equal monthly installments over the applicable time period. The provision establishes a state option for a hardship exemption for individuals for whom the denial of Medicaid eligibility based on such income would cause an undue medical or financial hardship as determined by criteria established by the HHS Secretary. States are required to inform individuals in advance of their loss of Medicaid eligibility of their option to enroll in a qualified health plan offered through the health insurance exchange during a special enrollment period (due to the loss of Medicaid or CHIP coverage) and to provide technical assistance to assist such individuals in enrolling in such coverage. States are also required to inform each individual of the date that such individual is permitted to reapply for Medicaid. The provision defines "qualified lottery winnings" as winnings (including amounts awarded as a lump sum payment) from a state-conducted sweepstakes or lottery, or a lottery operated by a multistate or multijurisdictional lottery association. The provision defines "qualified lump sum" income as income received as a lump sum from monetary winnings from gambling (as defined by the HHS Secretary and including monetary winnings from gambling activities described in section 1955(b)(4) of title 18 of the United States Code ). The provision specifies that states may recover lottery winnings awarded to the individual to pay for Medicaid medical assistance furnished to the individual. Prescription drugs are an optional benefit for states, but all states cover outpatient drugs for Medicaid beneficiaries. For states to receive matching federal medical assistance payments for purchasing covered outpatient drugs for Medicaid beneficiaries, a drug's manufacturer must have entered into a rebate agreement with the HHS Secretary. The Medicaid Drug Rebate Program (MDRP) agreement obligates drug manufacturers to provide a discount to state Medicaid programs on covered outpatient drug purchases. In exchange, by voluntarily agreeing to the MDRP terms, drug manufacturers are guaranteed that Medicare and Medicaid will cover most of their drug products that are approved for marketing by the Food and Drug Administration (FDA). In general, Medicaid-covered outpatient drugs include FDA-approved drugs requiring a prescription, including biologic drugs and insulin, but not vaccines or when drug payment is included as part of another service. FDA considers biologic drugs to be those derived from natural sources (human, animal, and microorganism) that are used to treat diseases and medical conditions. In this discussion, references to covered outpatient drugs also apply to biological drugs. Medicaid rebates on covered drugs include a basic rebate and an additional rebate, which together comprise the statutory total rebate. The basic rebate is the greater of either (1) the difference between the best price and the drug's Average Manufacturer Price (AMP) or (2) a specified percentage of the drug's AMP, which varies depending on the type of drug. The additional rebate owed for each drug is the amount the manufacturer increased the drug's AMP above the product's inflation-rate-adjusted AMP since the product was introduced. As the manufacturer increases the drug's AMP above the inflation rate, it owes a larger additional rebate. Under previous law, modifications to existing drug products, such as new doses or formulations, generally were considered new products for determining drug manufacturers' Medicaid rebate obligations. As a result, drug manufacturers could incur a lower additional rebate when they introduced a new line-extension formulation that was based on an existing product. For example, under previous law, drug manufacturers often introduced extended-release formulations of existing products that were considered new products. While line-extension formulations generally are introduced at a higher price than the reference product from which they were derived, the additional rebate is calculated from the most recent date of introduction of the line-extension rather than from the date the reference product was introduced. As a result, drug manufacturers often owe an additional rebate on the reference product, but owe little or no additional rebate on the line-extension drug introduced at a later date. Drug manufacturers may reduce their Medicaid rebate obligations as sales of line-extension drugs quickly exceed sales of their reference products due to the more favorable characteristics of the line extensions, such as extended release formulations, that are preferred by consumers over multiple-dose formulations. Section 53104 amends SSA Section 1927(c)(2)(C) to clarify drug manufacturers' Medicaid rebate obligations on oral solid dose innovator single and multiple source line-extension drugs. Under Section 53104, drug manufacturers owe the greater of either (1) the statutory total Medicaid rebate—basic rebate plus additional rebate—for the line-extension drug or, (2) the statutory total rebate for the product from which the line extension was developed. Section 53104 also removes a reference in statute to extended-release formulations as an example of line-extension products. Section 53104 is effective for rebate periods beginning on or after October 1, 2018. The HHS Secretary was required to establish the Medicaid Improvement Fund and use funds to improve the management of the Medicaid program, including oversight of contracts and contractors and evaluation of demonstration projects. Appropriations for the Medicaid Improvement Fund have been modified repeatedly, but the funding has not yet been obligated for the purposes described in the authorizing legislation. For FY2021 and thereafter, Congress appropriated $5 million for the Medicaid Improvement Fund to be available for expenditures. In addition, Congress appropriated $980 million to the Medicaid Improvement Fund for the Secretary to fund state activities related to mechanized claims processing systems beginning on or after FY2023. The Secretary is permitted to obligate Medicaid Improvement Fund resources in advance of future appropriations as long as the total amount obligated does not exceed the amount available to the fund. Section 53105 amends SSA Section 1941(b) to rescind the $5 million appropriated for the Medicaid Improvement Fund for FY2021 and thereafter. Section 53105 also rescinds the $980 million from the Medicaid Improvement Fund appropriated for the Secretary to use to fund state activities related to mechanized claims systems for FY2023 and thereafter. Appendix A. Acronyms Used in the Report

Summary: The Bipartisan Budget Act of 2018 (BBA 2018, P.L. 115-123), which was enacted on February 9, 2018, addresses a number of issues that were before Congress. For example, appropriations for most federal agencies and programs were to expire on February 8, 2018, and BBA 2018 extends continuing appropriations for these agencies and programs through March 23, 2018. In addition, BBA 2018 includes FY2018 supplemental appropriations, an increase to the debt limit, increases to the statutory spending limits for FY2018 and FY2019, tax provisions, and numerous provisions extending or making changes to mandatory spending programs, among other topics. Division E of BBA 2018 is titled the Advancing Chronic Care, Extenders, and Social Services (ACCESS) Act, which includes provisions affecting the following programs: Medicare; Medicaid; the State Children's Health Insurance Program (CHIP); public health programs; the Maternal, Infant, and Early Childhood Home Visiting (MIECHV) program; foster care and child welfare; social impact partnerships; child support enforcement; and prison data reporting. This report provides information about the provisions from Division E of BBA 2018 related to CHIP, certain public health programs, the MIECHV program, and the Medicaid program. BBA 2018 extends CHIP funding and other CHIP-related provisions (i.e., the Child Enrollment Contingency Fund, the qualifying states option, the Express Lane Eligibility option, the maintenance of effort [MOE] for children, the Pediatric Quality Measures Program, and the outreach and enrollment program) for FY2024 through FY2027. BBA 2018 extends funding for a number of public health programs that were funded through direct appropriations. Among the programs that receive additional funding through BBA 2018 for FY2018 and FY2019 are two Special Diabetes Programs, funding for the Health Professions Opportunity Grant Program, and the National Health Service Corps. BBA 2018 also extends funding, and in some cases increased funding, with programmatic changes for the Family-to-Family Health Information Program, an abstinence education program now known as the Sexual Risk Avoidance Education program; the Personal Responsibility Education Program (which relates to teen pregnancy prevention); the health center program; and the teaching health center graduate medical education program. In addition, the law reduces the amounts appropriated to the Public Health and Prevention Fund as a funding offset. BBA 2018 also extends funding of $400 million annually for the MIECHV program from FY2017 through FY2022. It requires states and other jurisdictions to continue to track and report on performance outcomes. It also allows jurisdictions to use some MIECHV funding for a pay-for-outcomes initiative, among other changes. BBA 2018 includes some Medicaid provisions as offsets. These Medicaid offsets are related to (1) Medicaid disproportionate share hospital (DSH) allotments; (2) the third-party liability (TPL) rules; (3) consideration of "qualified lottery winnings" and/or "qualified lump sum income" when determining Medicaid eligibility; (4) the rebate obligation with respect to line-extension drugs; and (5) the Medicaid Improvement Fund. This report provides a table with abbreviated summaries for the provisions in Division E of BBA 2018 related to CHIP, certain public health programs, the MIECHV program, and the Medicaid program. The table is followed by detailed summaries for each of these provisions, including background information and descriptions of the BBA 2018 provision.